Feliciano Zenaida MD is categorized under Internal Medicine Practitioners in Los Angeles, CA and active since 2010.
Feliciano Zenaida MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Zenaida Feliciano at the company’s single location by writing to 200 Ucla Medical Plaza, Los Angeles, California CA 90095 or by phoning (310) 206-8388. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Feliciano Zenaida MD |
| Contact Person: | Zenaida Feliciano |
| Address: | 200 Ucla Medical Plaza, Los Angeles, California 90095 |
| Phone Number: | (310) 206-8388 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Feliciano Zenaida MD was started in 2010 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Zenaida Feliciano for inquiries that concern Feliciano Zenaida MD by calling the company number (310) 206-8388, as your correspondence is most welcome. Additionally, the physical location of the single location of Feliciano Zenaida MD can be found at the coordinates 34.07019,-118.45102 as well as the street address 200 Ucla Medical Plaza in Los Angeles, California 90095.
For its online presence, you may visit Feliciano Zenaida MD’s website at and engage with its social media outlets through on Twitter and on Facebook.